Authorities Seal Illegal Drug Manufacturing Unit in Uttarakhand

In a significant crackdown on the illicit pharmaceutical trade, authorities in Uttarakhand have sealed a manufacturing facility in Kotdwar following an investigation into the production of counterfeit medicines. The operation, conducted by a joint team including the Uttarakhand Special Task Force (STF), targeted a unit known as M/s Nectar Herbs and Drugs, situated in the SIDCUL Sigaddi industrial area.

Investigation Details and Regulatory Violations

The enforcement action follows an ongoing campaign known as “Operation Fake Pill,” which aims to disrupt the supply chain of counterfeit drugs. According to officials, the inspection revealed that the facility was operating despite having its drug manufacturing license revoked in 2024. The investigation into the unit was initiated after a team from the Telangana Police recovered a substantial quantity of counterfeit medications and fake packaging materials from the premises.

During the recent raid, authorities discovered machinery and various raw materials allegedly intended for the production of unauthorized drugs. Officials have stated that these operations constitute prima facie violations of the Drugs and Cosmetics Act, 1940, as well as other statutory provisions governing factory operations.

Past Allegations and Counterfeit Remdesivir

The facility has come under intense scrutiny due to its alleged involvement in the production of counterfeit Remdesivir injections during the peak of the second wave of the COVID-19 pandemic in 2021. Remdesivir, an antiviral medication, was in high demand during that period, and the discovery of illicit manufacturing linked to the site has drawn significant attention from law enforcement.

The STF has linked the current enforcement action to the interrogation of two individuals, identified as Jatin Saini and Gaurav Tyagi, who were previously arrested for their involvement in the supply of counterfeit medicines. Following the raid, the owner of the facility, identified as Vishad Kumar, has been identified as a person of interest who is currently evading authorities.

Key Takeaways

• Facility Sealed: The Nectar Herbs and Drugs unit in Kotdwar was shut down by a joint task force after evidence of illegal manufacturing was uncovered.
• Regulatory Status: The factory’s drug manufacturing license had been officially revoked in 2024, yet the site remained operational.
• Pandemic-Era Allegations: The unit is accused of manufacturing fake Remdesivir injections during the 2021 COVID-19 health crisis.
• Legal Action: Authorities have seized raw materials and machinery, and the site remains sealed pending further legal proceedings.

Public Health Implications

The circulation of counterfeit drugs poses a severe threat to public health. These products often lack active ingredients, contain incorrect substances, or are produced in unsanitary conditions, rendering them ineffective or dangerous. The successful identification and closure of this unit represent a critical step in maintaining the integrity of the pharmaceutical supply chain and protecting consumers from substandard medical products.

As the investigation continues, law enforcement remains focused on tracking those responsible for the facility’s operations. The sealing of the unit serves as a stark reminder of the importance of rigorous regulatory oversight and the necessity of ongoing inter-agency cooperation in the fight against medical fraud.